Smith & Nephew logo

SN. - Smith & Nephew Share Price

1652p -11.0  -0.7%

Last Trade - 20/11/19

Large Cap
Market Cap £14.55bn
Enterprise Value £16.13bn
Revenue £3.83bn
Position in Universe 77th / 1846
Unlock SN. Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


SN. Revenue Unlock SN. Revenue

Net Income

SN. Net Income Unlock SN. Revenue

Normalised EPS

SN. Normalised EPS Unlock SN. Revenue

PE Ratio Range

SN. PE Ratio Range Unlock SN. Revenue

Dividend Yield Range

SN. Dividend Yield Range Unlock SN. Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
SN. EPS Forecasts Unlock SN. Revenue
Profile Summary

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

Last Annual December 31st, 2018
Last Interim June 29th, 2019
Incorporated February 17, 1937
Public Since August 13, 1951
No. of Shareholders: 14,301
No. of Employees: 16,000
SN. Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for SN.
Upcoming Events for SN.
Thursday 20th February, 2020
Full Year 2019 Smith & Nephew PLC Earnings Release
Friday 10th April, 2020 Estimate
Smith & Nephew PLC Annual Shareholders Meeting
Similar to SN.
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.